A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the U.S.

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

A Connecticut resident was diagnosed with a life-altering disease almost a year ago and while waiting to be seen at a UConn Health clinic, his wife spotted a flyer about a study that’s seeking a ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

ALPHARETTA, Ga., Jan. 27, 2026 /PRNewswire/ -- Avion Pharmaceuticals, an Alora Pharmaceuticals subsidiary company focused on advancing treatment for Parkinson's disease, is proud to announce the ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, led by researchers at UCL and Newcastle University. The £26 million project ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements. Subscribe to our ...